These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 25218488
1. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet. Sarkar S, Ooi SM, Liew CV, Tan BX, Heng PW. Int J Pharm; 2014 Nov 20; 475(1-2):558-65. PubMed ID: 25218488 [Abstract] [Full Text] [Related]
2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach. Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E. AAPS PharmSciTech; 2016 Feb 20; 17(1):214-32. PubMed ID: 26757898 [Abstract] [Full Text] [Related]
3. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules. Mehta S, De Beer T, Remon JP, Vervaet C. Int J Pharm; 2012 Jan 17; 422(1-2):310-7. PubMed ID: 22101283 [Abstract] [Full Text] [Related]
4. Evaluation of disintegrants functionality for orodispersible mini tablets. Soulairol I, Chaheen M, Tarlier N, Aubert A, Bataille B, Sharkawi T. Drug Dev Ind Pharm; 2017 Nov 17; 43(11):1770-1779. PubMed ID: 28581832 [Abstract] [Full Text] [Related]
8. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825 [Abstract] [Full Text] [Related]
10. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations. Rasool BK, Fahmy SA, Galeel OW. Pak J Pharm Sci; 2012 Oct 01; 25(4):815-22. PubMed ID: 23009999 [Abstract] [Full Text] [Related]
11. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS. Meka VS, Yee P, Sheshala R. Acta Pol Pharm; 2016 Oct 01; 73(2):469-78. PubMed ID: 27180440 [Abstract] [Full Text] [Related]
12. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI. Quodbach J, Moussavi A, Tammer R, Frahm J, Kleinebudde P. Int J Pharm; 2014 Nov 20; 475(1-2):605-12. PubMed ID: 25234864 [Abstract] [Full Text] [Related]
15. Functionality of disintegrants with different mechanisms after roll compaction. Berkenkemper S, Keizer HL, Lindenberg M, Szepes A, Kleinebudde P. Int J Pharm; 2020 Jun 30; 584():119434. PubMed ID: 32439584 [Abstract] [Full Text] [Related]
16. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants. Haque SE, Sheela A. Int J Nanomedicine; 2015 Jun 30; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321 [Abstract] [Full Text] [Related]
17. The influence of ethanol on superdisintegrants and on tablets disintegration. Bisharat L, AlKhatib HS, Muhaissen S, Quodbach J, Blaibleh A, Cespi M, Berardi A. Eur J Pharm Sci; 2019 Mar 01; 129():140-147. PubMed ID: 30630089 [Abstract] [Full Text] [Related]